Selected research
Industry Research
Flunixin Meglumine Injection Industry Research Report 2026
Market perspective
The global Flunixin Meglumine Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Flunixin Meglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Flunixin Meglumine Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Flunixin Meglumine Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Flunixin Meglumine Injection include Wuhan Huisheng Biological Technology Co., Ltd., Shandong Zhongmu Veterinary Medicine Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd., Qilu Animal Health Products Co., Ltd., Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd., Hebei New Century Pharmaceutical Co., Ltd., Baimukang Animal Pharmaceutical Co., Ltd., Zoteis and Virbac Animal Health India Private Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Flunixin Meglumine Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Flunixin Meglumine Injection Market by Company
Wuhan Huisheng Biological Technology Co., Ltd.
Shandong Zhongmu Veterinary Medicine Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
Hebei New Century Pharmaceutical Co., Ltd.
Baimukang Animal Pharmaceutical Co., Ltd.
Zoteis
Virbac Animal Health India Private Limited
Norbrook
MSD Animal Health
Merck Animal Health
Bengal Remedies Limited
Flunixin Meglumine Injection Segment by Type
10ml/Dose
20ml/ Dose
Flunixin Meglumine Injection Segment by Application
Animal muscle pain
Animal febrile disease
Others
Flunixin Meglumine Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flunixin Meglumine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flunixin Meglumine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flunixin Meglumine Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Flunixin Meglumine Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Flunixin Meglumine Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Flunixin Meglumine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10ml/Dose
- 20ml/ Dose
Applications
- Animal muscle pain
- Animal febrile disease
- Others
Companies covered
- Wuhan Huisheng Biological Technology Co., Ltd.
- Shandong Zhongmu Veterinary Medicine Co., Ltd.
- Shandong Lukang Pharmaceutical Co., Ltd.
- Qilu Animal Health Products Co., Ltd.
- Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
- Hebei New Century Pharmaceutical Co., Ltd.
- Baimukang Animal Pharmaceutical Co., Ltd.
- Zoteis
- Virbac Animal Health India Private Limited
- Norbrook
- MSD Animal Health
- Merck Animal Health
- Bengal Remedies Limited
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Flunixin Meglumine Injection Market Size (2021-2032)
- 2.2.2 Global Flunixin Meglumine Injection Sales (2021-2032)
- 2.2.3 Global Flunixin Meglumine Injection Market Average Price (2021-2032)
- 2.3 Flunixin Meglumine Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10ml/Dose
- 2.3.3 20ml/ Dose
- 2.4 Flunixin Meglumine Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Animal muscle pain
- 2.4.3 Animal febrile disease
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Flunixin Meglumine Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Flunixin Meglumine Injection Sales (K Doses) of Manufacturers (2021-2026)
- 3.3 Global Flunixin Meglumine Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Flunixin Meglumine Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Flunixin Meglumine Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Flunixin Meglumine Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Flunixin Meglumine Injection, Product Type & Application
- 3.8 Global Manufacturers of Flunixin Meglumine Injection, Established Date
- 3.9 Global Flunixin Meglumine Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Huisheng Biological Technology Co., Ltd.
- 4.1.1 Wuhan Huisheng Biological Technology Co., Ltd. Company Information
- 4.1.2 Wuhan Huisheng Biological Technology Co., Ltd. Business Overview
- 4.1.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Portfolio
- 4.1.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments
- 4.2 Shandong Zhongmu Veterinary Medicine Co., Ltd.
- 4.2.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information
- 4.2.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Business Overview
- 4.2.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Portfolio
- 4.2.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments
- 4.3 Shandong Lukang Pharmaceutical Co., Ltd.
- 4.3.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Shandong Lukang Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
- 4.3.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Qilu Animal Health Products Co., Ltd.
- 4.4.1 Qilu Animal Health Products Co., Ltd. Company Information
- 4.4.2 Qilu Animal Health Products Co., Ltd. Business Overview
- 4.4.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Portfolio
- 4.4.5 Qilu Animal Health Products Co., Ltd. Recent Developments
- 4.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
- 4.5.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
- 4.5.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Hebei New Century Pharmaceutical Co., Ltd.
- 4.6.1 Hebei New Century Pharmaceutical Co., Ltd. Company Information
- 4.6.2 Hebei New Century Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
- 4.6.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Baimukang Animal Pharmaceutical Co., Ltd.
- 4.7.1 Baimukang Animal Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Baimukang Animal Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
- 4.7.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Zoteis
- 4.8.1 Zoteis Company Information
- 4.8.2 Zoteis Business Overview
- 4.8.3 Zoteis Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Zoteis Flunixin Meglumine Injection Product Portfolio
- 4.8.5 Zoteis Recent Developments
- 4.9 Virbac Animal Health India Private Limited
- 4.9.1 Virbac Animal Health India Private Limited Company Information
- 4.9.2 Virbac Animal Health India Private Limited Business Overview
- 4.9.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Portfolio
- 4.9.5 Virbac Animal Health India Private Limited Recent Developments
- 4.10 Norbrook
- 4.10.1 Norbrook Company Information
- 4.10.2 Norbrook Business Overview
- 4.10.3 Norbrook Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Norbrook Flunixin Meglumine Injection Product Portfolio
- 4.10.5 Norbrook Recent Developments
- 4.11 MSD Animal Health
- 4.11.1 MSD Animal Health Company Information
- 4.11.2 MSD Animal Health Business Overview
- 4.11.3 MSD Animal Health Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 MSD Animal Health Flunixin Meglumine Injection Product Portfolio
- 4.11.5 MSD Animal Health Recent Developments
- 4.12 Merck Animal Health
- 4.12.1 Merck Animal Health Company Information
- 4.12.2 Merck Animal Health Business Overview
- 4.12.3 Merck Animal Health Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Merck Animal Health Flunixin Meglumine Injection Product Portfolio
- 4.12.5 Merck Animal Health Recent Developments
- 4.13 Bengal Remedies Limited
- 4.13.1 Bengal Remedies Limited Company Information
- 4.13.2 Bengal Remedies Limited Business Overview
- 4.13.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Bengal Remedies Limited Flunixin Meglumine Injection Product Portfolio
- 4.13.5 Bengal Remedies Limited Recent Developments
5 Global Flunixin Meglumine Injection Market Scenario by Region
- 5.1 Global Flunixin Meglumine Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Flunixin Meglumine Injection Sales by Region: 2021-2032
- 5.2.1 Global Flunixin Meglumine Injection Sales by Region: 2021-2026
- 5.2.2 Global Flunixin Meglumine Injection Sales by Region: 2027-2032
- 5.3 Global Flunixin Meglumine Injection Revenue by Region: 2021-2032
- 5.3.1 Global Flunixin Meglumine Injection Revenue by Region: 2021-2026
- 5.3.2 Global Flunixin Meglumine Injection Revenue by Region: 2027-2032
- 5.4 North America Flunixin Meglumine Injection Market Facts & Figures by Country
- 5.4.1 North America Flunixin Meglumine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Flunixin Meglumine Injection Sales by Country (2021-2032)
- 5.4.3 North America Flunixin Meglumine Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Flunixin Meglumine Injection Market Facts & Figures by Country
- 5.5.1 Europe Flunixin Meglumine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Flunixin Meglumine Injection Sales by Country (2021-2032)
- 5.5.3 Europe Flunixin Meglumine Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Flunixin Meglumine Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Flunixin Meglumine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Flunixin Meglumine Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Flunixin Meglumine Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Flunixin Meglumine Injection Market Facts & Figures by Country
- 5.7.1 South America Flunixin Meglumine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Flunixin Meglumine Injection Sales by Country (2021-2032)
- 5.7.3 South America Flunixin Meglumine Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Flunixin Meglumine Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Flunixin Meglumine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Flunixin Meglumine Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Flunixin Meglumine Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Flunixin Meglumine Injection Sales by Type (2021-2032)
- 6.1.1 Global Flunixin Meglumine Injection Sales by Type (2021-2032) & (K Doses)
- 6.1.2 Global Flunixin Meglumine Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Flunixin Meglumine Injection Revenue by Type (2021-2032)
- 6.2.1 Global Flunixin Meglumine Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Flunixin Meglumine Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Flunixin Meglumine Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Flunixin Meglumine Injection Sales by Application (2021-2032)
- 7.1.1 Global Flunixin Meglumine Injection Sales by Application (2021-2032) & (K Doses)
- 7.1.2 Global Flunixin Meglumine Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Flunixin Meglumine Injection Revenue by Application (2021-2032)
- 7.2.1 Global Flunixin Meglumine Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Flunixin Meglumine Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Flunixin Meglumine Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Flunixin Meglumine Injection Value Chain Analysis
- 8.1.1 Flunixin Meglumine Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Flunixin Meglumine Injection Production Mode & Process
- 8.2 Flunixin Meglumine Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Flunixin Meglumine Injection Distributors
- 8.2.3 Flunixin Meglumine Injection Customers
9 Global Flunixin Meglumine Injection Analyzing Market Dynamics
- 9.1 Flunixin Meglumine Injection Industry Trends
- 9.2 Flunixin Meglumine Injection Industry Drivers
- 9.3 Flunixin Meglumine Injection Industry Opportunities and Challenges
- 9.4 Flunixin Meglumine Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst